| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jul―09 |
Identification of FDA-Approved Drugs That Inhibit SARS-CoV-2 and Human Norovirus Replication |
Tsuyoshi Hayashi, Junki Hirano, Kosuke Murakami, Yoshiki Fujii, Sakura Kobayashi, Takashi Tanikawa, et al. (+2) Masashi Kitamura, Yuichi Someya |
| 2 |
[GO] |
2025―May―16 |
Treatment of Long Coronavirus Disease in Japan: A Nationwide Study of Symptom-Associated Drug Prescriptions |
Yuka Kogure, Wataru Ando, Kyoka Sakamaki, Mitsuhiro Sugawara |
| 3 |
[GO] |
2025―Apr―23 |
Evaluation of the Influence of the National Action Plan on Antimicrobial Resistance and the COVID-19 Pandemic on the Consumption of Broad-Spectrum Antimicrobial and Anti-methicillin-resistant <i>Staphylococcus aureus</i> Agents |
Ryota Goto, Ryo Inose, Ryuji Koizumi, Keisuke Sawada, Masahiro Ishikane, Norio Ohmagari, Yuichi Muraki |
| 4 |
[GO] |
2024―Nov―07 |
Sunflower Trypsin Monocyclic Inhibitor Selected for the Main Protease of SARS-CoV-2 by Phage Display |
Graziele Cristina Ferreira, Verônica de Moraes Manzato, Debora Noma Okamoto, Livia Rosa Fernandes, Deivid Martins Santos, Gabriel Cerqueira Alves Costa, et al. (+5) Fernando Allan Abreu Silva, Ricardo Jose Soares Torquato, Giuseppe Palmisano, Maria Aparecida Juliano, Aparecida Sadae Tanaka |
| 5 |
[GO] |
2024―May―16 |
Computational Estimation of Residues Involving Resistance to the SARS-CoV-2 Main Protease Inhibitor Ensitrelvir Based on Virtual Alanine Scan of the Active Site |
Ayato Mizuno, Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda |
| 6 |
[GO] |
2024―May―16 |
Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease <i>in Vitro</i> |
Yuka Kiba, Takashi Tanikawa, Masashi Kitamura |
| 7 |
[GO] |
2024―Apr―30 |
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2 |
Yuichiro Yamamoto, Tetsuya Inoue |
| 8 |
[GO] |
2024―Apr―30 |
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne |
Mana Murae, Shota Sakai, Non Miyata, Yoshimi Shimizu, Yuko Okemoto-Nakamura, Takuma Kishimoto, et al. (+5) Motohiko Ogawa, Hideki Tani, Kazuma Tanaka, Kohji Noguchi, Masayoshi Fukasawa |
| 9 |
[GO] |
2023―Oct―20 |
Removal of soluble ACE2 in VeroE6 cells by 17β-estradiol reduces SARS-CoV-2 infectivity |
Yuta Kyosei, Teruki Yoshimura, Etsuro Ito |
| 10 |
[GO] |
2022―Oct―07 |
Safety of remdesivir in 20 children with COVID-19 -case series- |
Shuji Manabe, Shinsuke Mizuno, Tsuyoshi Jinda, Masashi Kasai |
| 11 |
[GO] |
2022―Sep―30 |
Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection |
Yasuhiro Hayashi, Kouki Matsuda, Kazunari Tanigawa, Takashi Tanikawa, Kenji Maeda, Kiyoto Tsuchiya |
| 12 |
[GO] |
2022―Jun―30 |
Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan |
Hideyuki Terazono, Masami Tsuchiya, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, et al. (+8) Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto, Fumio Itagaki, Hiroyuki Masuko, Masahito Yonemura, Mayako Uchida |
| 13 |
[GO] |
2022―Jan―21 |
Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis |
Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno |
| 14 |
[GO] |
2021―Jun―30 |
Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report |
Megumi Yahara, Kazuyuki Niki, Keita Ueno, Mio Okamoto, Takeshi Okuda, Hiroyuki Tanaka, et al. (+4) Yasuo Naito, Ryouhei Ishii, Mikiko Ueda, Toshinori Ito |
| 15 |
[GO] |
2021―Jun―18 |
Improved detection sensitivity of an antigen test for SARS-CoV-2 nucleocapsid proteins with thio-NAD cycling |
Yuta Kyosei, Mayuri Namba, Sou Yamura, Satoshi Watabe, Teruki Yoshimura, Tadahiro Sasaki, et al. (+2) Tatsuo Shioda, Etsuro Ito |
|
